Brian Scanlan

Vice President Corporate Development

Brian’s creativity in positioning the company has bolstered CML's name and image as a top-tier supplier of advanced chemistry services. He has overseen the business aspects of CML for the past 6 years, during which time the company has undergone average growth of greater than 30% per year.  Brian is responsible for developing and implementing corporate development strategies for the company, including sales and marketing, planning/forecasting, contracts/legal issues, and project management. He brings significant industry experience in creating deals tailored to the clients specific needs and has been involved in several pharmaceutical contract chemistry organizations over the past 15 years ranging from startups to large CMO's.

Prior to joining CML, Brian managed business development activities in North America for Rhodia ChiRex focusing on the emerging pharma and biotech sectors. Prior to Rhodia ChiRex, he helped form the startup company, Universal Pharma Technologies, where he was responsible for all technical sales and marketing efforts. The company was later acquired by Johnson Matthey. Brian started his career with petrochemical giant UOP where he was a R&D chemist, then later moved into the specialty chemicals group in various marketing roles.

He received his MBA from the Stuart School of Business, Illinois Institute of Technology, and a BS in Chemistry from Northern Illinois University.

Brian currently serves on the Board of Directors of the Wisconsin Biotechnology and Medical Device Association, and is active in several industry organizations.